ResMed Releases New S9™ Series Flow Generators

San Diego, CA - February 26, 2010

ResMed Corp. (NYSE: RMD) today released their new S9™ Series of flow generators, a radical evolution in continuous positive airway pressure (CPAP) therapy.

The S9 Series combines sophisticated treatment technology with novel user-friendly controls in a stylish new design that departs dramatically from that of its predecessors.

“Our goal in the development of the S9 was to create a system that offers more than any other device on the market – more comfort, more control and more style – so users can feel confident about incorporating it into their lifestyle, and healthcare providers can be confident that their patients are receiving the highest quality of sleep apnea treatment,” stated Drew Terry, Sr. Director of Product Management.

“In essence, the S9 represents a new approach to achieving patient compliance: making it as easy as possible for users to accept CPAP on their own terms. It puts them in control of the details that make the difference in their personal comfort, like EPR™ level and humidification settings. It has intuitive menus and dials to make it easy to adjust. It reduces noise to a virtual whisper, so it won’t disrupt a sleeping partner. And it comes in a stylish design that looks like something they want to have at their bedside,” added Terry.

With the S9 Series, ResMed has introduced a number of improvements to their time-tested technologies, including Enhanced AutoSet™ and Easy-Breathe algorithms, and an improved Easy-Breathe motor for unprecedented quiet. They’ve also incorporated a state-of-the-art humidification system with Climate Control, which intelligently adapts to the user’s real-time environmental conditions to provide optimum performance and humidification delivery. Additionally, they’ve introduced an innovative tube design with the SlimLine™ tube, which virtually eliminates tube drag.

In market trials, users have responded enthusiastically. “I don't feel the pressure changes as my needs increase. The breathing feels more natural, drops in EPR feel smoother, and I have zero rainout throughout the night,” reported one respondent. 

Another respondent said, “This is the best, hands down, CPAP I have ever slept with, and I have slept with virtually all of them on the market. The Climate Control is awesome. I do not ever want to go back to sleeping with another CPAP.”

The S9 has received accolades from clinicians as well. “With the S9, there’s a sense of value that other products on the market do not have. The engineering behind it is what appeals to me; not just what it looks like, but what it can do. The Easy-Breathe technology, in combination with Climate Control and the SlimLine tube … everything has come together to make it very easy for a patient to accept therapy,” commented Dennis Janes, RRT, of Alegent Health Home Medical Equipment.

In addition to the numerous clinical and comfort features, the S9 provides detailed data reporting for clinicians. A complete S9-compatible wireless compliance management package is available to streamline business efficiencies for ResMed customers.

Terry concluded, “We believe the S9 sets a new industry standard in combining technical innovation with comfort and aesthetics. We expect it to be a tremendous market success.”

View the ResMed S9 Elite
View the ResMed S9 Autoset

For more information about ResMed’s new S9 Series, call ResMed Customer Service at 800.424.0737, or visit www.S9MoreComfort.com .

About ResMed
ResMed is a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders.  We are dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated SDB. For more information on ResMed, visit www.resmed.com.

Statements contained in this release that are not historical facts are “forward-looking” statements as contemplated by the Private Securities Litigation Reform Act of 1995. These forward-looking statements, including statements regarding the Company's future revenue, earnings or expenses, new product development and new markets for the Company's products, are subject to risks and uncertainties, which could cause actual results to materially differ from those projected or implied in the forward-looking statements. Those risks and uncertainties are discussed in the Company's Annual Report on Form 10-K for its most recent fiscal year and in other reports the Company files with the U.S. Securities & Exchange Commission. Those reports are available on the Company's Web site.